« October 2009 | Main | December 2009 »

November 29, 2009

meds

The U.S. Food and Drug Administration said Friday it has approved a new vaccine to prevent seasonal influenza.

Agriflu, made by Novartis Vaccines and Diagnostics, is not intended to protect against the H1N1 virus, commonly known as swine flu.

The vaccine was approved using an accelerated approval process, the FDA said. Novartis demonstrated that the vaccine induces levels of antibodies in the blood that are effective in preventing seasonal influenza, but it still needs to conduct further studies.

Doug

CDIstaffing.com

November 28, 2009

Diabetes

The number of Americans with diabetes will nearly double in the next 25 years, and the costs of treating them will triple, according to a new report.

The figures, in a University of Chicago report released Friday, add fuel to the congressional debate regarding reining in the cost of health care.

By 2034, 44.1 million Americans will be living with diabetes -- nearly twice the current number of 23.7 million, according to the report, published in the December issue of the journal Diabetes Care. About 90 percent of those with diabetes have type 2, a version of the condition that develops over time.

Doug

CDIstaffing.com

November 25, 2009

Swine Flu

 China has detected eight cases of swine flu mutation, a health official said Wednesday, amid longstanding concerns among scientists that the virus could change into a more dangerous form.

Last week, the World Health Organization said it was investigating samples of variant swine flu linked to two deaths in Norway.

But Shu Yuelong, director of the Chinese National Influenza Center, told the official Xinhua News Agency that the mutated swine flu virus found China has shown an "isolated" spread in the mainland, is not resistant to drugs and can be prevented by vaccines.

Doug

CDIstaffing.com

November 24, 2009

Smoking

If you need another reason to stop smoking while pregnant, or to rid your home of lead, a new study suggests that children whose mothers smoked during pregnancy and who are exposed to the metal have more than twice the usual risk of attention-deficit/hyperactivity disorder (ADHD). Study co-author Dr. Tanya E. Froehlich, of Cincinnati Children's Hospital Medical Center in Ohio, told Reuters Health that the lead finding is particularly "surprising," given that the blood lead levels in the study children -- even those in the top third of the sample - were, on average, about a tenth of the threshold for harmful effects set by the U.S. Centers for Disease Control and Prevention. "These are not high levels of lead exposure; they are historically what we would consider to be low levels," Froehlich said.

Doug

CDIstaffing.com

November 23, 2009

Smoking

Children whose mothers smoked during pregnancy or who were exposed to lead have more than double the risk of having attention-deficit hyperactivity disorder as other children, new resea

 

Children whose mothers smoked during pregnancy and whose blood showed signs of lead exposure had eight times the risk of having ADHD.

Doug

CDIstaffing.com

 

November 22, 2009

Health Reform

Each bill creates a public option. The Senate bill allows states to opt out.

Individual mandate

Each bill requires people to buy insurance or pay a penalty -- $750 by 2016 in the Senate bill and 2.5 percent of income in the House bill.

Subsidies/exchanges

Each bill sets up insurance marketplaces, called exchanges, in which people without access to affordable coverage through an employer can buy plans. Subsidies are available to households earning up to 400 percent of the poverty level, or $88,200 for a family of four.

Employer mandate

The Senate bill does not require employers to offer health insurance, but it fines employers with more than 50 employees if even one receives a subsidy through the new exchanges. The fine is equal to $750 for every person on the payroll.

The House bill requires employers to pay 65 percent of family premiums or pay a penalty based on payroll; businesses with less than $500,000 in payroll are exempt.

Abortion provision

The Senate bill bars the use of federal funds for abortion but doesn't go as far as the House bill. It requires at least one plan in the exchange to offer abortion and one that doesn't.

The House bill bans abortion from being covered in the public option or in the exchange's private plans that take subsidized costumers. There is an exemption if a woman's life is in danger or in cases of rape or incest.

Medicaid expansion

The Senate bill expands Medicaid to cover everyone earning less than 133 percent of the federal poverty level, or $29,327 for a family of four.

The House bill expands Medicaid to cover households earning less than 150 percent of the federal poverty level, or $33,075 for a family of four.

Insurance reforms

Each bill includes bans on lifetime limits, premium disparity based on health status and sex, and coverage denials based on preexisting conditions.

Doug

CDIstaffing.com

November 21, 2009

Mortality

Diarrhea doesn't make headlines. Nor does pneumonia. AIDS and malaria tend to get most of the attention.

Yet even though cheap tools could prevent and cure both diseases, they kill an estimated 3.5 million kids under 5 each a year globally — more than HIV and malaria combined.

"They have been neglected, because donor or partnership mechanisms shifted their emphasis to HIV and AIDS and other issues," said Dr. Tesfaye Shiferaw, a UNICEF official in Africa. "These age-old traditional killers remain with us. The ones dying are the children of the poor."

Global spending on maternal, newborn and child health was about $3.5 billion in 2006, according to a report by the Bill & Melinda Gates Foundation. That same year, nearly $9 billion was devoted to HIV and AIDS, according to UNAIDS.

Pneumonia is the biggest killer of children under 5, claiming more then 2 million lives annually or about 20 percent of all child deaths. AIDS, in contrast, accounts for about 2 percent.

Doug

CDIstaffing.com

November 20, 2009

Downs syndrome


New research may provide the foundation for future medical treatment of memory deficits associated with Down syndrome http://kona.kontera.com/javascript/lib/imgs/grey_loader.gif

 The research was conducted in mice that were genetically engineered to have a condition similar to Down syndrome, a genetic disorder.

It is still not clear if humans would benefit from the findings.

Still, the researchers found that mice with the syndrome-like condition could use their brains

more effectively when the signaling of norepinephrine, a neurotransmitter that helps nerve cells communicate, was boosted.

"If you intervene early enough, you will be able to help kids with Down syndrome to collect and modulate information," Dr. Ahmad Salehi, the study's primary author, said in a news release from Stanford University Medical Center. "Theoretically, that could lead to an improvement in cognitive functions in these kids." Salehi, a research health science specialist at the Veterans Affairs Palo Alto Health Care System, in California, was a senior scientist at Stanford when the study was conducted.

Doug

CDIstaffing.com

November 17, 2009

meds

It isn't often that a study involving a couple of hundred people shakes up medical science.

That's what happened Monday, when doctors formally reported that lowly niacin, a B vitamin, did a significantly better job of shrinking artery plaque than a billion-dollar blockbuster called ezetimibe, the active ingredient in the cholesterol drugs Zetia and Vytorin.

"The results are very clear," says lead investigator Allen Taylor of the Medstar Research Institute. "Niacin was superior

Doug

CDIstaffing.com

November 15, 2009

Smoking

After decades of progress, the number of Americans who smoke hasn't budged over the last five years and actually rose slightly from 2007 to 2008, according to a new report from the CDC.

Smoking

After decades of progress, the number of Americans who smoke hasn't budged over the last five years and actually rose slightly from 2007 to 2008, according to a new report from the CDC.

November 13, 2009

Meds

Stainless steel fragments and other foreign particles were found in a small percentage of several of Genzyme Corp (GENZ.O) rare disease drugs, U.S. regulators said on Friday.

Rememeber to use a filter needle, every time you draw up IV meds.

Doug

CDIstaffing.com

Meds

Stainless steel fragments and other foreign particles were found in a small percentage of several of Genzyme Corp (GENZ.O) rare disease drugs, U.S. regulators said on Friday.

Rememeber to use a filter needle, every time you draw up IV meds.

Doug

CDIstaffing.com

November 10, 2009

Procrit and stroke risk

New research on cancer patients adds to the controversy surrounding anemia drugs such as Procrit and Aranesp, concluding that they increase the risk of venous thromboembolism, potentially fatal blood clots.

 

These drugs, called erythropoiesis-stimulating agents (ESAs), are commonly prescribed to fight anemia associated with chemotherapy and chronic kidney disease. Recent studies have linked them with increased risk of death, stroke and new cancers.

 

 Doug

CDIstaffing.com

Obesity vs. MS

 Obesity in adolescent girls may increase risk for multiple sclerosis later in life, a study shows.

Researchers examined data on more than 238,000 women who participated in the Nurses' Health Study, which began in 1976, and the Nurses' Health Study II, which began in 1989. Participants self-reported what their height and weight were at the start of the study and what they had been at age 18. They also chose silhouettes to describe their body shapes when they were ages 5, 10, and 20 years old. Participants were between 25 and 55 years old when the studies began.

Doug

CDIstaffing.com

November 05, 2009

Meds

About 1.5 million preventable "adverse drug events" occur in the United States every year, according to a 2007 study by the Institute of Medicine, part of the National Academy of Sciences. Aside from the toll on health, the errors cost an estimated $4 billion a year, the study found.

"I was frankly stunned at the scope of the problem," FDA Commissioner Margaret Hamburg said at a news conference Wednesday. The plan, dubbed the Safe Use Initiative, "is something that doesn't require a new scientific discovery or a budget appropriation."

The FDA called on doctors, other healthcare professionals and consumers to help identify drugs and circumstances that may be particular problems. The agency will hold public hearings to gather information, said Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research.

Doug

CDIstaffing.com

November 04, 2009

Meds

Rockville-based Human Genome Sciences announced Monday that its experimental lupus drug has completed its final round of testing at a higher dose and will be headed to the Food and Drug Administration for approval.

The latest round of studies on the experimental drug Benlysta showed that a sufficient number of lupus patients given a higher dosage of the drug showed improvement after a year, which enabled the drug to meet its target. A lower dosage of the drug did not meet that target.

Doug

CDIstaffing.com

November 03, 2009

Birth Defects

Penicillin, which is the most commonly used antibiotic during pregnancy, as well as erythromycin, cephalosporins and quinolones, other widely prescribed antibiotics, were not associated with increased risk for about 30 different birth defects.

However, the study found that two types of antibiotics were linked with a higher risk for several birth defects: nitrofurantoins and sulfonamides, sometimes called "sulfa drugs," which are prescribed for urinary tract and other infections.

Women whose children had anencephaly, a fatal malformation of the skull and brain, were three times more likely to have taken sulfonamides, the study found. Sulfonamides were also tied to an increased risk for such heart defects as hypoplastic left heart syndrome and coarctation of the aorta, choanal atresia (a blockage of the nasal passage), transverse limb deficiency and diaphragmatic hernia, an abnormal opening in the diaphragm that results in severe breathing difficulties

Doug

CDIstaffing.com